Description
The authors are supported by grants from the Novo Nordisk Foundation (NNF14OC0011493, NNF17OC0030088 and NNF14OC0009941), Swedish Diabetes Foundation (DIA 2018-357, DIA2018-336), Swedish Research Council (2015-00165, 2018-02389), the Strategic Research Program in Diabetes at Karolinska Institutet (2009-1068), the Stockholm County Council (SLL20170159), the Swedish Research Council for Sport Science (P2018-0097) and the EFSD European Research Programme on New Targets for Type 2 Diabetes supported by an educational research grant from MSD. LD was supported by a Novo Nordisk postdoctoral fellowship run in partnership with Karolinska Institutet. BMG was supported by a fellowship from the Wenner-Gren Foundation (Sweden). NJP and LSP were supported by the Marie Skłodowska-Curie Actions (European Commission, 704978, 675610) and grants from the Sigurd och Elsa Goljes Minne and Lars Hiertas Minne Foundations (Sweden). We acknowledge the Beta Cell in-vivo Imaging/ Extracellular Flux Analysis core facility supported by the Strategic Research Program (SRP) in Diabetes for the usage of the Seahorse flux analyzer.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Unknown Resource | Unknown | Open resource | |
| Unknown Resource | Unknown | Open resource | |
| Unknown Resource | Unknown | Open resource |